External application patch for treating diabetes

Abstract

The invention discloses an external application patch for treating diabetes. The external application patch comprises a medical non-woven fabric layer, a medicinal layer and a protective layer from inside to outside, wherein the medicinal layer comprises external application powder and TPR pectin. The external application patch is prepared by the following steps: after uniformly mixing the external application powder and TPR pectin, smearing on a non-woven fabric; and then embedding the non-woven fabric into the protective layer to prepare the external application patch. The external application patch comprises the following raw materials in parts by weight: 10-15 parts of sticktight, 10-15 parts of purslane, 8-12 parts of semen cuscutae, 8-12 parts of pollen typhae, 8-12 parts of cortex mori radicis, 5-10 parts of radix asparag, 5-10 parts of flatstem milkvetch seeds, 3-7 parts of codonopsis pilosula and 3-7 parts of rhizoma anemarrhenae. The external application patch disclosed by the invention can be used for reducing blood sugar to normal level within a short time, relapse is avoided within a short time after drug withdrawal, and the external application patch has the function of reducing blood pressure.

Description

technical field [0001] The invention relates to a medicine for treating diabetes, in particular to an external plaster for treating diabetes. Background technique [0002] Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is caused by defective insulin secretion or impaired biological action, or both. The long-term high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves. There is currently no cure for diabetes, and diabetes is usually controlled through a variety of treatments. [0003] At present, common hypoglycemic drugs are mainly divided into two categories: traditional Chinese medicine or western medicine: hypoglycemic is a slow process, usually diabetic patients need to take drugs for a long time to achieve the goal of maintaining normal blood pressure, the cost is relatively high, and ordinary families cannot bear it Long-term drug ...

AI Technical Summary

Problems solved by technology

[0003] At present, common hypoglycemic drugs are mainly divided into two categories: traditional Chinese medicine or western medicine: hypoglycemic is a slow process, usually diabetic patients need to take drugs for a long time to achieve the goal of maintaining normal blood pressure, the cost is relatively high, and ordinary families cannot bear it Long-term drug supply, and Western medicine usually contains antibiotics or hormones, although it can quickly lower blood sugar, but it is difficult to achieve the goal of a radical cure, and it is easy to relapse; , The gastrointestinal mucosa will also cause certain irritating damage, so it is not easy to take it for a long time

Traditional Chinese medicine is mild in nature, has no toxic and side effects on the human body, and can achieve the purpose of radical cure, but the curative effect is relatively slow; and the processing of traditional Chinese medicine is relatively rough, the taste is poor, and it is difficult to exert its due efficacy, or the high-temperature concentration and refining process destroys the medicine. original role

Images